Table 1.
Clinical characteristics of IBM patients and controls
| IBM patients (N = 20) | Controls (N = 20) | Unpaired t test p value |
|
|---|---|---|---|
| Age (years), mean ± SD | 61.4 ± 12.3 | 68.06 ± 9.59 | 0.83 |
| Females, n (%) | 7 (35) | 7 (35) | 1.00 |
| Arterial hypertension (AHT), n (%) | 13 (65) | 5 (25) | 0.01 |
| Diabetes, n (%) | 2 (10) | 1 (5) | 0.08 |
| CK (norm < 171), (U/l) | 613 ± 467 | – | – |
| CKMB (norm < 25) (U/l) | 37 ± 21 | – | – |
| Troponin I (norm < 14) (ng/l) | 4.0 ± 4.0 | – | – |
| NT-pro BNP (norm 0–125) (pg/ml) | 232 ± 389 | – | – |
| Angiotensin-converting enzyme (ACE) inhibitor or angiotensin 1 receptor blocker (n) | 10 | – | – |
| Beta-blocker (n) | 8 | – | – |
| Other antihypertensive medications (n) | 9 | – | – |
| AVB grade II (n) | 0 | – | – |
| Atrial fibrillation (n) | 0 | – | – |
| Supraventricular tachycardia (n) | 0 | – | – |
Bold value indicate p < 0.05
NSVT non-sustained ventricular tachycardia, AVB atrioventricular block, VPC/h ventricular premature contractions/hour